In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum

MLA

Erik Koehne, et al. “In Vitro Activity of Eravacycline, a Novel Synthetic Halogenated Tetracycline, against the Malaria Parasite Plasmodium Falciparum.” Journal of Global Antimicrobial Resistance, vol. 24, no. 93–97, Mar. 2021, pp. 93–97. EBSCOhost, https://doi.org/10.1016/j.jgar.2020.11.024.

APA

Erik Koehne, Andrea Kreidenweiss, Bayode Romeo Adegbite, Rella Zoleko Manego, Matthew B.B. McCall, Ghyslain Mombo-Ngoma, Ayola Akim Adegnika, Sélidji Todagbé Agnandji, Benjamin Mordmüller, & Jana Held. (2021). In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum. Journal of Global Antimicrobial Resistance, 24(93–97), 93–97. https://doi.org/10.1016/j.jgar.2020.11.024

Chicago

Erik Koehne, Andrea Kreidenweiss, Bayode Romeo Adegbite, Rella Zoleko Manego, Matthew B.B. McCall, Ghyslain Mombo-Ngoma, Ayola Akim Adegnika, Sélidji Todagbé Agnandji, Benjamin Mordmüller, and Jana Held. 2021. “In Vitro Activity of Eravacycline, a Novel Synthetic Halogenated Tetracycline, against the Malaria Parasite Plasmodium Falciparum.” Journal of Global Antimicrobial Resistance 24 (93–97): 93–97. doi:10.1016/j.jgar.2020.11.024.